Eur Heart J:急性心肌梗死住院时间与院内死亡率之间的关系

2019-02-10 xing.T MedSci原创

由此可见,几乎没有证据支持AMI住院时间和院内死亡率之间的关联;合并疾病和治疗可能解释院内死亡率的差异。

近日,血管领域权威杂志Eur Heart J上发表了一篇研究文章,研究人员旨在明确急性心肌梗死(AMI)住院时间与住院死亡率之间的关系。

该研究纳入了2004年1月1日至2013年3月31日期间在英格兰和威尔士的243家医院因ST段抬高心肌梗死(STEMI)和非STEMI(NSTEMI)住院的患者。结局指标是院内死亡率。使用多重Logistic回归、反向概率加权倾向得分和工具变量分析估计24小时时间内通过6个4小时时间段的院内死亡率调整后比值比(OR)。

在615035例患者中[中位年龄70.0岁,四分位数范围为59.0-80.0岁; 406519(66.0%)为男性],有52777名(8.8%)患者住院死亡。在晚上,NSTEMI患者出现并发症更频繁,并且对于STEMI患者从症状发作至再灌注时间更长。对于STEMI患者未调整的院内死亡率在20:00至23:59之间最高[4小时期间范围为8.4-9.9%,与00:00-03:59比较OR为1.13,95%置信区间(CI)为1.07-1.20],并且对于NSTEMI在12:00-15:59之间死亡最高(8.0-8.8%; 与00:00-03:59比较的OR为1.07,95%CI为1.03-1.12)。然而,这些差异仅在研究的早期阶段才明显,并且通过调整人口统计学指标、合并症和临床表现而减弱。在调整所提供的急性临床治疗后,差异无统计学意义。

由此可见,几乎没有证据支持AMI住院时间和院内死亡率之间的关联;合并疾病和治疗可能解释院内死亡率的差异。

原始出处:


Jianhua Wu.et al.Association between time of hospitalization with acute myocardial infarction and in-hospital mortality.Eur Heart J.https://doi.org/10.1093/eurheartj/ehy835

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1635241, encodeId=dee61635241ee, content=<a href='/topic/show?id=bb41983049e' target=_blank style='color:#2F92EE;'>#院内死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98304, encryptionId=bb41983049e, topicName=院内死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78f122436081, createdName=yuhaisheng_ibp_32061718, createdTime=Sun Sep 15 18:25:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357098, encodeId=a7b0135e09824, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 12 12:25:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407133, encodeId=ef46140e133d0, content=<a href='/topic/show?id=d0db264464a' target=_blank style='color:#2F92EE;'>#住院时间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26446, encryptionId=d0db264464a, topicName=住院时间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfbf2593024, createdName=crystal0563, createdTime=Tue Feb 12 12:25:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563055, encodeId=ef751563055ff, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Tue Feb 12 12:25:00 CST 2019, time=2019-02-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1635241, encodeId=dee61635241ee, content=<a href='/topic/show?id=bb41983049e' target=_blank style='color:#2F92EE;'>#院内死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98304, encryptionId=bb41983049e, topicName=院内死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78f122436081, createdName=yuhaisheng_ibp_32061718, createdTime=Sun Sep 15 18:25:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357098, encodeId=a7b0135e09824, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 12 12:25:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407133, encodeId=ef46140e133d0, content=<a href='/topic/show?id=d0db264464a' target=_blank style='color:#2F92EE;'>#住院时间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26446, encryptionId=d0db264464a, topicName=住院时间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfbf2593024, createdName=crystal0563, createdTime=Tue Feb 12 12:25:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563055, encodeId=ef751563055ff, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Tue Feb 12 12:25:00 CST 2019, time=2019-02-12, status=1, ipAttribution=)]
    2019-02-12 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=1635241, encodeId=dee61635241ee, content=<a href='/topic/show?id=bb41983049e' target=_blank style='color:#2F92EE;'>#院内死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98304, encryptionId=bb41983049e, topicName=院内死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78f122436081, createdName=yuhaisheng_ibp_32061718, createdTime=Sun Sep 15 18:25:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357098, encodeId=a7b0135e09824, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 12 12:25:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407133, encodeId=ef46140e133d0, content=<a href='/topic/show?id=d0db264464a' target=_blank style='color:#2F92EE;'>#住院时间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26446, encryptionId=d0db264464a, topicName=住院时间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfbf2593024, createdName=crystal0563, createdTime=Tue Feb 12 12:25:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563055, encodeId=ef751563055ff, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Tue Feb 12 12:25:00 CST 2019, time=2019-02-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1635241, encodeId=dee61635241ee, content=<a href='/topic/show?id=bb41983049e' target=_blank style='color:#2F92EE;'>#院内死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98304, encryptionId=bb41983049e, topicName=院内死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78f122436081, createdName=yuhaisheng_ibp_32061718, createdTime=Sun Sep 15 18:25:00 CST 2019, time=2019-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357098, encodeId=a7b0135e09824, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 12 12:25:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407133, encodeId=ef46140e133d0, content=<a href='/topic/show?id=d0db264464a' target=_blank style='color:#2F92EE;'>#住院时间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26446, encryptionId=d0db264464a, topicName=住院时间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfbf2593024, createdName=crystal0563, createdTime=Tue Feb 12 12:25:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563055, encodeId=ef751563055ff, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Tue Feb 12 12:25:00 CST 2019, time=2019-02-12, status=1, ipAttribution=)]
    2019-02-12 slcumt

相关资讯

Circ Cardiovasc Qual:急性心梗无心衰患者停用β-受体阻滞剂有何影响?

2018年4月,发表在《Circ Cardiovasc Qual Outcomes》的一项由法国科学家进行的队列研究,考察了急性心肌梗死(AMI)后接受最佳治疗的无心衰患者停用β-受体阻滞剂后的临床事件发生风险。

JAHA:急性心肌梗塞并发心源性休克住院患者出院后30天再住院患病率、原因及预测因素!

由此可见,急性心肌梗死并发心源性休克的患者出院后30天内近5分之一的患者再次入院,主要原因包括心力衰竭和新发AMI等心脏原因。再入院风险与某些基线患者/医院特征有关。

Circ Cardiovasc Qual:我国西医医院治疗急性心梗中药使用情况面面观

2018年5月,发表在《Circ Cardiovasc Qual Outcomes》的一项由中国和美国科学家进行的分析,考察了中国西医医院使用中药(TCM)治疗急性心肌梗死(AMI)的情况。

Circ-Heart Fail:急性心肌梗死和心源性休克患者30天再入院的原因及预测因素!

由此可见,AMI合并心源性休克患者住院病死率和30天入院率明显升高。患者再入院的主要原因为非心脏病因。高危因素的识别可以指导干预,以改善该群体的结局。

Eur Heart J-Card Img:慢性阻塞性肺疾病急性心肌梗死后左室整体纵向应变与长期预后!

由此可见,左心室GLS受损与伴有COPD的STEMI患者糟糕的长期生存率独立相关,并会增加LVEF的预测价值。

Int J Cardiol:非急性心肌梗死相关心源性休克患者的住院死亡率和30天再入院率!

由此可见,住院期间死亡率和非AMI的CS住院患者30天再住院率均显著升高。大多数再入院是由于非心血管病因。识别高危因素可能有助于制定策略来提高护理质量并降低不良结局发生率。